Free Letter - District Court of Delaware - Delaware

Case 1:04-cv-00833-KAJ Document 90-8 Filed O9/O1/2005 Page 1 of 3
EXHIBIT F

Case 1:04—cv—00833-KAJ Document 90-8 Filed 09/01/2005 Page 2 of 3
I I C4
mb McDonnell Bnehnen Hulbert & Berghoff i.u· sooseoinwaeieorivs zuzoisooui phen Q
I I Chicago, Iliinois 50605-6709 312913 0002 fax pa.;
wwwmbhbcom W
i····r
*-3
March 30, 2005 **17
Sent Via Facsimile {212) 768-6800
Brian T. Nloriany
Sonnenschein Nath & Rosenthal LLP
1221 Avenue of the Americas
New York, New York 10020
Re: Pharmacia & Upjohn Company LLC v. Sicor inc. and Sicor Pharmaceuticals, inc.
Civii Action No. 04833
U.S. District Court for the District of Delaware
Dear Brian:
We received Sicor’s initial document production yesterday and were surprised both by the
lack of content (only two haitfilled boxes) and the narrow subject matter. The entirety of
Sicor's initiai document production was what appears to be its Abbreviated New Drug
Application for the accused product. We have begun reviewing these rnateriais and wiil
complete our review as soon as possible, but, in the meantime, please confirm whether
these materials comprise the complete coiiection of tiles that Sicor maintains in relation to
regulatory approval for the accused product. Regardless of the completeness ot the ANDA
tile, however, Sicor appears not to have produced documents responsive to many issues.
ln tact, other than providing a copy of Sicor’s ANDA, Sicor's initial document production
iaiied to respond or deal with any other issue. We scarcely believe this refiects Judge
Jordans admonition at the close oi the March 17, 2005 hearing that "both sides . . . pick
up the ball, move it more sensibly and better? Sicor produced no information pertaining to
its invaiidity defenses, other atiirmative defenses, or other issues. The deficiencies are
especially giaring given Sicor’s reliance on Ruie 33id) to respond to Pharmacia & Upjohn’s
interrogatories. Please advise how Sicor's initial document production satisfies its Rule
33ldl obligations ior each of the interrogatories for which it was invoked; otherwise piease
provide substantive responses to the interrogatories.
ln order to move discovery forward more sensibly, we request production of additional
relevant documents and complete responses to Pharmacia & Lipjohn's interrogatories hy
next Monday, April 4, 2005. Piease iet us know whether Sicor wili be complying with our
request by the close oi business on Friday.

Case 1:04-cv-00833-KAJ Document 90-8 Filed O9/O1/2005 Page 3 of 3
Pieasa feel free to contact me if you have any questions.
Vozy truiy yours,
Joshua R. Rich
3].2 913 2133
[email protected]
cc: John G. Day
Maryeilen Noraika
McDunneEi Bushman Hulbert & Berghuff LLP 8rian T Mnriaiiy 2 March 30, 2005